Price $31.52 |
Market Cap
1.82B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.34
|
P/S
42.57
|
Dividend %
-
|
|
P/CF
52.8
|
P/FCF
-
|
Op. Cash Flow
-372.6K
|
FCF
-5.9
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
110.20%
|
ROI
-
|
|
ROA
94.80%
|
EPS Growth
557.90%
|
Current Ratio
6.7
|
Debt/Equity
0.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co (BMY) | $62.46 | - | 3.50% | 138.77B | Strong Buy |
| Acura Pharmaceuticals, Inc. (ACUR) | $0.47 | - | - | 32.8M | Strong Buy |
| Paratek Pharmaceuticals Inc (PRTK) | $3.96 | - | - | 223.3M | Strong Buy |
| Castlight Health Inc (CSLT) | $2.04 | - | - | 251.3M | Strong Buy |
| Anika Therapeutics Inc (ANIK) | $32.24 | - | - | 525.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
